Relates to the continuation of the empire state stem cell board; makes such provisions of law permanent.
Summary
Bill S01318 seeks to amend the public health law to continue the operations of the Empire State Stem Cell Board, which is responsible for administering the Empire State Stem Cell Trust Fund. The bill empowers the board to make grants for research and development activities that advance scientific discoveries in stem cell biology. The current law stipulates that the board's grant-making authority is set to expire on December 31, 2025, and this bill aims to make the provisions of law permanent, ensuring ongoing support for stem cell research in New York.
Impact
If enacted, this bill would have a significant impact on state laws by removing the expiration date for the Empire State Stem Cell Board's authority to make grants. It would ensure that funding for stem cell research continues without interruption, potentially leading to advancements in medical science and biotechnology. The bill reinforces New York's commitment to being a leader in stem cell research and could attract further investment and interest in the state's scientific community.
Sentiment
The general sentiment around Bill S01318 appears to be supportive, as it aligns with ongoing efforts to promote scientific research and innovation in New York. There has been no recorded opposition or significant contention during committee discussions or voting, indicating a consensus on the importance of continuing the Empire State Stem Cell Board's work.
Contention
While there are no notable points of contention currently documented in the discussions or voting history regarding this bill, potential future debates could arise around the ethical implications of stem cell research or the allocation of state funds to such initiatives. Stakeholders in the medical and ethical communities may have varying perspectives on these issues, but no specific opposition has been noted at this time.
AN ACT relating to public health and safety; authorizing physicians to recommend and perform stem cell therapy on patients as specified; allowing health care insurers to cover stem cell therapy as specified; prohibiting the state board of medicine from taking action against a physician's license due to the use or promotion of stem cell therapy; prohibiting the state of Wyoming from denying patients access to stem cell therapy; providing that no cause of action is created against a person properly performing stem cell therapy; requiring compliance as specified; amending the powers of the Wyoming state board of medicine; providing definitions; and providing for an effective date.